Background: Continuous changes in stroke treatment and care, as well as changes in stroke characteristics, may alter stroke outcome over time. The aim of this paper is to describe time trends for treatment and outcome data, and to discuss if any such changes could be attributed to quality changes in stroke care. Methods: Data from Riks-Stroke, the Swedish stroke register, were analyzed for the time period of 1995 through 2010. The total number of patients included was 320,181. The following parameters were included: use of computed tomography (CT), stroke unit care, thrombolysis, medication before and after the stroke, length of stay in hospital, and discharge destination. Three months after stroke, data regarding walking, toileting and dressing ability, as well social situation, were gathered. Survival status after 7, 27 and 90 days was registered. Results: In 1995, 53.9% of stroke patients were treated in stroke units. In 2010 this proportion had increased to 87.5%. Fewer patients were discharged to geriatric or rehabilitation departments in later years (23.6% in 2001 compared with 13.4% in 2010), but more were discharged directly home (44.2 vs. 52.4%) or home with home rehabilitation (0 vs. 10.7%). The need for home help service increased from 18.2% in 1995 to 22.1% in 2010. Regarding prevention, more patients were on warfarin, antihypertensives and statins both before and after the stroke. The functional outcome measures after 3 months did improve from 2001 to 2010. In 2001, 83.8% of patients were walking independently, while 85.6% were independent in 2010. For toileting, independence increased from 81.2 to 84.1%, and for dressing from 78.0 to 80.4%. Case fatality (CF) rates after 3 months increased from 18.7% (2001) to 20.0% (2010). This trend is driven by patients with severe strokes. Conclusions: Stroke outcomes may change over a relatively short time period. In some ways, the quality of care has improved. More stroke patients have CT, more patients are treated in stroke units and more have secondary prevention. Patients with milder strokes may have benefited more from these measures than patients with severe strokes. Increased CF rates for patients with severe stroke may be caused by shorter hospital stays, shorter in-hospital rehabilitation periods and lack of suitable care after discharge from hospital.

1.
National Board of Health and Welfare: Access to In-Hospital Beds (in Swedish). Stockholm, National Board of Health and Welfare, 2010.
2.
National Board of Health and Welfare: Statistical Database. Stockholm, National Board of Health and Welfare, 2013. http://www.socialstyrelsen.se/statistik/statistikdatabas (accessed March 21, 2013).
3.
Asplund K, Hulter Åsberg K, Appelros P, Bjarne D, Eriksson M, Johansson A, Jonsson F, Norrving B, Stegmayr B, Terént A, Wallin S, Wester PO: The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care. Int J Stroke 2011;6:99-108.
4.
Stegmayr B, Asplund K, Hulter Åsberg K, Norrving B, Peltonen M, Terént A, Wester PO: Stroke units in their natural habitat: can results of randomized trials be reproduced in routine clinical practice? Riks-Stroke Collaboration. Stroke 1999;30:709-714.
5.
Asplund K, Hulter Åsberg K, Norrving B, Stegmayr B, Terént A, Wester PO: Riks-Stroke: a Swedish national quality register for stroke care. Cerebrovasc Dis 2003;15(suppl 1):5-7.
6.
Riks-Stroke Collaboration: Riks-Stroke. http://www.riks-stroke.org (accessed March 21, 2013).
7.
Appelros P, Jonsson F, Asplund K, Eriksson M, Glader EL, Hulter Åsberg K, Norrving B, Stegmayr B, Terént A: Trends in baseline patient characteristics during the years 1995-2008: observations from Riks-Stroke, the Swedish Stroke Register. Cerebrovasc Dis 2010;30:114-119.
8.
Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T: Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113-130.
9.
Starmark JE, Stålhammar D, Holmgren E: The Reaction Level Scale (RLS85): manual and guidelines. Acta Neurochir (Wien) 1988;91:12-20.
10.
R Project for Statistical Computing: Software R. R Foundation, 2008. http://www.r-project.org/ (accessed 2013).
11.
National Board of Health and Welfare: National Guidelines for Stroke Care 2009 (Swedish). Stockholm, National Board of Health and Welfare, 2009.
12.
Singer OC, Hamann GF, Misselwitz B, Steinmetz H, Foerch C: Time trends in systemic thrombolysis in a large hospital-based stroke registry. Cerebrovasc Dis 2012;33:316-321.
13.
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
14.
Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, Davies R, Östergren J, Probstfield J: Use of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324:699-703.
15.
Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
16.
Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY: Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010;123:638-645.e634.
17.
Swedish Government: A life with dignity in eldercare (Swedish). Stockholm, Swedish Government, 2008. http://www.regeringen.se/sb/d/108/a/106288 (accessed August 1, 2013).
18.
Jørgensen HS, Kammersgaard LP, Houth J, Nakayama H, Raaschou HO, Larsen K, Hübbe P, Olsen TS: Who benefits from treatment and rehabilitation in a stroke unit? A community-based study. Stroke 2000;31:434-439.
19.
Terént A, Asplund K, Farahmand B, Henriksson KM, Norrving B, Stegmayr B, Wester PO, Hulter Åsberg K, Åsberg S: Stroke unit care revisited: who benefits the most? A cohort study of 105,043 patients in Riks-Stroke, the Swedish Stroke Register. J Neurol Neurosurg Psychiatry 2009;80:881-887.
20.
Rønning OM, Guldvog B: Outcome of subacute stroke rehabilitation: a randomized controlled trial. Stroke 1998;29:779-784.
21.
Islam MS, Anderson CS, Hankey GJ, Hardie K, Carter K, Broadhurst R, Jamrozik K: Trends in incidence and outcome of stroke in Perth, Western Australia, during 1989 to 2001: the Perth Community Stroke Study. Stroke 2008;39:776-782.
22.
Meretoja A, Kaste M, Roine RO, Juntunen M, Linna M, Hillbom M, Marttila R, Erilä T, Rissanen A, Sivenius J, Häkkinen U: Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007: PERFECT Stroke, a nationwide register study. Ann Med 2011;43(suppl 1):S22-S30.
23.
Rieks S, Willich SN, Mueller-Riemenschneider F: Trends in age-standardized and age-specific cerebrovascular mortality in Germany between 1980 and 2009. Cerebrovasc Dis 2012;34:368-375.
24.
Appelros P, Terént A: Validation of the Swedish inpatient and cause-of-death registers in the context of stroke. Acta Neurol Scand 2011;123:289-293.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.